Abstract
People with Parkinson's disease (PwPD) exhibit a significant reduction in muscle strength, which negatively affects locomotion. These impairments increase the risk of falls and reduce quality of life. Pharmacological treatment partially improves muscle strength and locomotion in PwPD. As a result, complementary therapies have been explored in PwPD, such as transcranial direct current stim…